A new study has found that reduced glutathione, when combined with entecavir, significantly improves liver function, reduces fibrosis, and enhances HBV-DNA clearance in chronic hepatitis B patients.

The government has started Hepatitis C control pilot program in two districts of Gilgit-Baltistan under the Prime Minister's  National ...

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...

The award recognizes UB work that leveraged facilitated telemedicine to cure hepatitis C in 90% of people with opioid use disorder.

Dynavax Technologies Corporation ( NASDAQ: DVAX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - ...

A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...

A novel approach developed by a UB physician-scientist and colleagues to cure hepatitis C virus in people with opioid use ...

This expansion is part of the NHS Blood Borne Virus (BBV) opt-out testing programme, which will now include an additional 30 ...